# OnCo record cognitive-and-mood-effects-on-lorlatinib-and-avapritinib (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/cognitive-and-mood-effects-on-lorlatinib-and-avapritinib/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "cognitive-and-mood-effects-on-lorlatinib-and-avapritinib" ;
  schema:name "Cognitive, mood and speech effects on lorlatinib, and cognitive effects on avapritinib"@en ;
  schema:alternateName "CNS effects of lorlatinib"@en, "lorlatinib brain fog"@en, "memory problems on lorlatinib"@en, "mood changes on lorlatinib"@en, "hallucinations on lorlatinib"@en, "cognitive effects of avapritinib"@en, "memory impairment on avapritinib"@en, "neurocognitive adverse events of ALK inhibitors"@en ;
  schema:description "Lorlatinib and avapritinib can affect memory, thinking and mood; lorlatinib can also change speech or cause hallucinations. These effects usually improve when the dose is paused or lowered, so tell your team about new forgetfulness, confusion, mood changes, thoughts of suicide, or seeing or hearing things that are not real. The EU lorlatinib leaflet says immediately. Family may notice first."@en ;
  schema:url <https://onco.cc/protocols/cognitive-and-mood-effects-on-lorlatinib-and-avapritinib/> ;
  schema:dateModified "2026-11-18"^^xsd:date ;
  onco:related <https://onco.cc/protocols/fluid-retention-and-effusions-on-kinase-inhibitors/>, <https://onco.cc/protocols/distress-screening-and-referral/>, <https://onco.cc/protocols/driving-flying-and-travel-during-cancer-treatment/>, <https://onco.cc/protocols/anticancer-drug-interaction-review/>, <https://onco.cc/protocols/raised-lipids-and-weight-gain-on-lorlatinib-bexarotene-and-elacestrant/> ;
  onco:drugs <https://onco.cc/drugs/lorlatinib/>, <https://onco.cc/drugs/avapritinib/> ;
  onco:terms <https://onco.cc/terms/ctcae-grading/>, <https://onco.cc/terms/dose-modification/> .
